CDKL5 DEFICIENCY DISORDER
Clinical trials for CDKL5 DEFICIENCY DISORDER explained in plain language.
Never miss a new study
Get alerted when new CDKL5 DEFICIENCY DISORDER trials appear
Sign up with your email to follow new studies for CDKL5 DEFICIENCY DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to tame seizures in rare childhood disorder
Disease control Not yet recruitingThis study tests whether the drug ganaxolone can reduce seizures in children aged 6 months to 2 years with CDKL5 deficiency disorder, a rare genetic condition causing hard-to-control seizures. Twenty children will receive either ganaxolone or a placebo alongside their usual seizu…
Matched conditions: CDKL5 DEFICIENCY DISORDER
Phase: PHASE3 • Sponsor: Immedica Pharma AB • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Hot baths tested as seizure treatment for rare childhood disorder
Symptom relief Not yet recruitingThis study tests whether taking a daily hot bath (40-42°C for 20 minutes) at home can reduce epileptic seizures in children with CDKL5 deficiency disorder. The trial will include 34 children aged 6 months to 14 years whose seizures are not controlled by medication. Researchers wi…
Matched conditions: CDKL5 DEFICIENCY DISORDER
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC